Kratom Derivatives & Value Structure

From raw leaf to high-purity extract, our product range is designed to meet diverse industrial needs with consistent quality and scientific rigor.

About Property

Our products are developed based on the concentration and application of Mitragynine, the primary active compound in kratom.

Open Custom

Microbial Safety

Heavy Metals Screening

Alkaloid profile analysis

Mitragynine - Primary Alkaloid of Mitragyna Speciosa

A high-value bioactive compound widely utilized in pharmaceutical and nutraceutical applications, known for its functional and research relevance.

0.5% – 1.5%

Natural Content Range

Primary Alkaloid

Core Active Component

Bioactive Compound

Scientifically Relevant

Global Demand

Pharma & Nutraceutical Industry

Industrial Applications

Raw Leaf powder

  • 0.5-1.5% Mitragynine
  • Low value
  • Raw export material

Extract

  • 50-65%
  • High concentration
  • Export-focused

Formulated Product (Gummies)

  • Infused with kratom extract
  • Flavored, easy-to-consume format
  • Ready for end-user applications

Formulated Product (Tablets, Capsules & Gelcaps)

  • Solid oral dosage forms
  • Kratom powder or extract based
  • Encapsulated or compressed formats
  • Ready for standardized consumption

All products are tested under standardized laboratory protocols.

Our extraction process is engineered to deliver consistent Mitragynine concentrations with verified purity across every batch. From raw leaf selection to refined extract, each stage is controlled to ensure reliability, traceability, and industrial-grade standards.

We support long-term supply needs for research, manufacturing, and formulation industries by maintaining strict quality control, standardized processes, and certified production outputs.